Atlas Trials

Multicenter, Open-label, Safety and Tolerability Study

Clinical trial NCT01649557 · COMPLETED

Trial details

NCT number
NCT01649557
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2009-08-01
Primary completion
2011-08-01
Enrollment
244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.